Pharmabiz

Alkermes reports positive results from Vibrance-2 phase 2 study of once-daily alixorexton in patients with narcolepsy type 2

Alkermes reports positive results from Vibrance-2 phase 2 study of once-daily alixorexton in patients with narcolepsy type 2: Dublin Friday, November 14, 2025, 18:00 Hrs [IST] Alk ...
Scientific Research Publishing

The Impact of China’s Tax Reform on Per Capita Income: A Regional Analysis Based on Tourism, E-Commerce, and Education Sectors ()

A Regional Analysis Based on Tourism, E-Commerce, and Education Sectors This study assesses the impact of China’s Value-Added Tax (VAT) and Individual Income Tax (IIT) reforms on per capita income ...
Open Heart

Cardiac CT in the era of artificial intelligence: precision imaging, treatment guidance and optimised risk stratification for coronary artery disease

Coronary artery disease (CAD) remains a leading cause of morbidity and mortality worldwide, and CT imaging plays a crucial ...
Goldseiten

EcoGraf Limited: Epanko Expansion Supports EcoGraf HFfree® Downstream Facilities

EcoGraf is pleased to announce the Epanko Graphite Project Expansion Study examined the potential to expand production to support the Company's strategy of developing its commercial scale EcoGraf ...